The miR-29a was significantly lower expressed in HCC tissues as compared to the controls and overexpression of miR-29a suppressed HCC cell growth by inhibiting the SPARC (Secreted protein acidic, rich in cysteine)-AKT pathway [85]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.